PYC Therapeutics Ltd (ASX: PYC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
PYC Therapeutics Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
PYC Therapeutics Ltd (ASX: PYC)
Latest News
Share Gainers
Why these three ASX All Ords stocks are leading the charge higher this week
Share Gainers
Why IDP Education, Novonix, PYC, and Regis Resources share are racing higher
Small Cap Shares
2 ASX penny stocks to consider buying while their prices are this cheap
Share Gainers
Why Appen, Mayne Pharma, Playside, and PYC shares are storming higher
Healthcare Shares
Guess which ASX All Ords insider just bought 50 million shares in their company
Share Fallers
Why IDP Education, JB Hi-Fi, PYC, and Renascor shares are falling today
Share Fallers
Why Arcadium Lithium, IAG, PYC Therapeutics, and Zip shares are falling today
Share Market News
Why is the PYC Therapeutics share price up 170% in a year?
Share Market News
Why the PYC Therapeutics (ASX:PYC) share price is up 11% today
Share Market News
Why the PYC Therapeutics (ASX:PYC) share price is up 9% today
⏸️ Investing
Why Phylogica Limited soared 80% today
❮2
PYC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About PYC Therapeutics Ltd
PYC Therapeutics Ltd. is a drug-development company, which offers a new generation of RNA therapeutics to meet unmet need in disease. It develops intracellular biological therapeutics including its own preclinical oncology payloads, using its proprietary cell Functional Penetrating Phylomers. The company was founded by Richmond Miles Hopkins and Paul Michael Watt on October 9, 2001 and is headquartered in Nedlands, Australia.
